nodes	percent_of_prediction	percent_of_DWPC	metapath
Foscarnet—SLC16A1—Methotrexate—systemic scleroderma	0.331	0.534	CbGbCtD
Foscarnet—SLC22A6—Captopril—systemic scleroderma	0.219	0.354	CbGbCtD
Foscarnet—SLC22A6—Methotrexate—systemic scleroderma	0.0693	0.112	CbGbCtD
Foscarnet—Paraesthesia—Leflunomide—systemic scleroderma	0.000294	0.000773	CcSEcCtD
Foscarnet—Myalgia—Lisinopril—systemic scleroderma	0.000293	0.000772	CcSEcCtD
Foscarnet—Chest pain—Lisinopril—systemic scleroderma	0.000293	0.000772	CcSEcCtD
Foscarnet—Arthralgia—Lisinopril—systemic scleroderma	0.000293	0.000772	CcSEcCtD
Foscarnet—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000293	0.000772	CcSEcCtD
Foscarnet—Anxiety—Lisinopril—systemic scleroderma	0.000292	0.000769	CcSEcCtD
Foscarnet—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000292	0.000768	CcSEcCtD
Foscarnet—Dyspnoea—Leflunomide—systemic scleroderma	0.000292	0.000768	CcSEcCtD
Foscarnet—Hypotension—Mycophenolic acid—systemic scleroderma	0.000292	0.000768	CcSEcCtD
Foscarnet—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00029	0.000764	CcSEcCtD
Foscarnet—Discomfort—Lisinopril—systemic scleroderma	0.00029	0.000763	CcSEcCtD
Foscarnet—Dyspepsia—Leflunomide—systemic scleroderma	0.000288	0.000758	CcSEcCtD
Foscarnet—Pancreatitis—Prednisone—systemic scleroderma	0.000288	0.000758	CcSEcCtD
Foscarnet—Vomiting—Mometasone—systemic scleroderma	0.000287	0.000756	CcSEcCtD
Foscarnet—Dry mouth—Lisinopril—systemic scleroderma	0.000287	0.000755	CcSEcCtD
Foscarnet—Sweating increased—Prednisone—systemic scleroderma	0.000286	0.000753	CcSEcCtD
Foscarnet—Feeling abnormal—Azathioprine—systemic scleroderma	0.000285	0.000751	CcSEcCtD
Foscarnet—Rash—Mometasone—systemic scleroderma	0.000285	0.00075	CcSEcCtD
Foscarnet—Asthenia—Captopril—systemic scleroderma	0.000285	0.00075	CcSEcCtD
Foscarnet—Dermatitis—Mometasone—systemic scleroderma	0.000285	0.000749	CcSEcCtD
Foscarnet—Decreased appetite—Leflunomide—systemic scleroderma	0.000284	0.000749	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000284	0.000748	CcSEcCtD
Foscarnet—Confusional state—Lisinopril—systemic scleroderma	0.000283	0.000746	CcSEcCtD
Foscarnet—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000283	0.000746	CcSEcCtD
Foscarnet—Headache—Mometasone—systemic scleroderma	0.000283	0.000745	CcSEcCtD
Foscarnet—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000283	0.000744	CcSEcCtD
Foscarnet—Insomnia—Mycophenolic acid—systemic scleroderma	0.000282	0.000743	CcSEcCtD
Foscarnet—Fatigue—Leflunomide—systemic scleroderma	0.000282	0.000742	CcSEcCtD
Foscarnet—Oedema—Lisinopril—systemic scleroderma	0.000281	0.00074	CcSEcCtD
Foscarnet—Pruritus—Captopril—systemic scleroderma	0.000281	0.000739	CcSEcCtD
Foscarnet—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00028	0.000738	CcSEcCtD
Foscarnet—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000737	CcSEcCtD
Foscarnet—Pain—Leflunomide—systemic scleroderma	0.00028	0.000736	CcSEcCtD
Foscarnet—Constipation—Leflunomide—systemic scleroderma	0.00028	0.000736	CcSEcCtD
Foscarnet—Infection—Lisinopril—systemic scleroderma	0.000279	0.000735	CcSEcCtD
Foscarnet—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000734	CcSEcCtD
Foscarnet—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000278	0.000732	CcSEcCtD
Foscarnet—Somnolence—Mycophenolic acid—systemic scleroderma	0.000277	0.00073	CcSEcCtD
Foscarnet—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000277	0.00073	CcSEcCtD
Foscarnet—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000275	0.000725	CcSEcCtD
Foscarnet—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000275	0.000723	CcSEcCtD
Foscarnet—Neutropenia—Prednisone—systemic scleroderma	0.000274	0.000723	CcSEcCtD
Foscarnet—Body temperature increased—Azathioprine—systemic scleroderma	0.000274	0.000721	CcSEcCtD
Foscarnet—Abdominal pain—Azathioprine—systemic scleroderma	0.000274	0.000721	CcSEcCtD
Foscarnet—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000272	0.000716	CcSEcCtD
Foscarnet—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000272	0.000715	CcSEcCtD
Foscarnet—Diarrhoea—Captopril—systemic scleroderma	0.000272	0.000715	CcSEcCtD
Foscarnet—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000271	0.000714	CcSEcCtD
Foscarnet—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00027	0.000711	CcSEcCtD
Foscarnet—Feeling abnormal—Leflunomide—systemic scleroderma	0.00027	0.00071	CcSEcCtD
Foscarnet—Fatigue—Mycophenolic acid—systemic scleroderma	0.000269	0.000708	CcSEcCtD
Foscarnet—Nausea—Mometasone—systemic scleroderma	0.000268	0.000707	CcSEcCtD
Foscarnet—Anorexia—Lisinopril—systemic scleroderma	0.000268	0.000705	CcSEcCtD
Foscarnet—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000267	0.000704	CcSEcCtD
Foscarnet—Ataxia—Methotrexate—systemic scleroderma	0.000267	0.000703	CcSEcCtD
Foscarnet—Constipation—Mycophenolic acid—systemic scleroderma	0.000267	0.000703	CcSEcCtD
Foscarnet—Pain—Mycophenolic acid—systemic scleroderma	0.000267	0.000703	CcSEcCtD
Foscarnet—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000267	0.000702	CcSEcCtD
Foscarnet—Weight decreased—Prednisone—systemic scleroderma	0.000266	0.000699	CcSEcCtD
Foscarnet—Cough—Mycophenolate mofetil—systemic scleroderma	0.000263	0.000693	CcSEcCtD
Foscarnet—Hypotension—Lisinopril—systemic scleroderma	0.000263	0.000691	CcSEcCtD
Foscarnet—Dizziness—Captopril—systemic scleroderma	0.000262	0.000691	CcSEcCtD
Foscarnet—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000261	0.000688	CcSEcCtD
Foscarnet—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00026	0.000686	CcSEcCtD
Foscarnet—Abdominal pain—Leflunomide—systemic scleroderma	0.000259	0.000681	CcSEcCtD
Foscarnet—Body temperature increased—Leflunomide—systemic scleroderma	0.000259	0.000681	CcSEcCtD
Foscarnet—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000257	0.000677	CcSEcCtD
Foscarnet—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000676	CcSEcCtD
Foscarnet—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000676	CcSEcCtD
Foscarnet—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000676	CcSEcCtD
Foscarnet—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000257	0.000675	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000256	0.000674	CcSEcCtD
Foscarnet—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000256	0.000674	CcSEcCtD
Foscarnet—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000256	0.000673	CcSEcCtD
Foscarnet—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000255	0.000672	CcSEcCtD
Foscarnet—Insomnia—Lisinopril—systemic scleroderma	0.000254	0.000669	CcSEcCtD
Foscarnet—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000254	0.000668	CcSEcCtD
Foscarnet—Paraesthesia—Lisinopril—systemic scleroderma	0.000252	0.000664	CcSEcCtD
Foscarnet—Vomiting—Captopril—systemic scleroderma	0.000252	0.000664	CcSEcCtD
Foscarnet—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000661	CcSEcCtD
Foscarnet—Dyspnoea—Lisinopril—systemic scleroderma	0.000251	0.00066	CcSEcCtD
Foscarnet—Rash—Captopril—systemic scleroderma	0.00025	0.000659	CcSEcCtD
Foscarnet—Dermatitis—Captopril—systemic scleroderma	0.00025	0.000658	CcSEcCtD
Foscarnet—Somnolence—Lisinopril—systemic scleroderma	0.00025	0.000658	CcSEcCtD
Foscarnet—Headache—Captopril—systemic scleroderma	0.000249	0.000655	CcSEcCtD
Foscarnet—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000248	0.000654	CcSEcCtD
Foscarnet—Dyspepsia—Lisinopril—systemic scleroderma	0.000247	0.000651	CcSEcCtD
Foscarnet—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000247	0.000649	CcSEcCtD
Foscarnet—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000247	0.000649	CcSEcCtD
Foscarnet—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000246	0.000648	CcSEcCtD
Foscarnet—Infection—Mycophenolate mofetil—systemic scleroderma	0.000245	0.000644	CcSEcCtD
Foscarnet—Decreased appetite—Lisinopril—systemic scleroderma	0.000244	0.000643	CcSEcCtD
Foscarnet—Fatigue—Lisinopril—systemic scleroderma	0.000242	0.000638	CcSEcCtD
Foscarnet—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000241	0.000635	CcSEcCtD
Foscarnet—Pancreatitis—Methotrexate—systemic scleroderma	0.00024	0.000633	CcSEcCtD
Foscarnet—Pain—Lisinopril—systemic scleroderma	0.00024	0.000633	CcSEcCtD
Foscarnet—Constipation—Lisinopril—systemic scleroderma	0.00024	0.000633	CcSEcCtD
Foscarnet—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000238	0.000627	CcSEcCtD
Foscarnet—Diarrhoea—Azathioprine—systemic scleroderma	0.000237	0.000624	CcSEcCtD
Foscarnet—Nausea—Captopril—systemic scleroderma	0.000236	0.000621	CcSEcCtD
Foscarnet—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000235	0.000618	CcSEcCtD
Foscarnet—Asthenia—Leflunomide—systemic scleroderma	0.000235	0.000618	CcSEcCtD
Foscarnet—Hallucination—Prednisone—systemic scleroderma	0.000234	0.000615	CcSEcCtD
Foscarnet—Pancytopenia—Methotrexate—systemic scleroderma	0.000233	0.000613	CcSEcCtD
Foscarnet—Feeling abnormal—Lisinopril—systemic scleroderma	0.000232	0.00061	CcSEcCtD
Foscarnet—Pruritus—Leflunomide—systemic scleroderma	0.000231	0.000609	CcSEcCtD
Foscarnet—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00023	0.000606	CcSEcCtD
Foscarnet—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00023	0.000605	CcSEcCtD
Foscarnet—Neutropenia—Methotrexate—systemic scleroderma	0.000229	0.000604	CcSEcCtD
Foscarnet—Dysuria—Methotrexate—systemic scleroderma	0.000229	0.000604	CcSEcCtD
Foscarnet—Dizziness—Azathioprine—systemic scleroderma	0.000229	0.000603	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000591	CcSEcCtD
Foscarnet—Asthenia—Mycophenolic acid—systemic scleroderma	0.000224	0.000589	CcSEcCtD
Foscarnet—Diarrhoea—Leflunomide—systemic scleroderma	0.000224	0.000589	CcSEcCtD
Foscarnet—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000223	0.000586	CcSEcCtD
Foscarnet—Abdominal pain—Lisinopril—systemic scleroderma	0.000222	0.000585	CcSEcCtD
Foscarnet—Body temperature increased—Lisinopril—systemic scleroderma	0.000222	0.000585	CcSEcCtD
Foscarnet—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000221	0.000582	CcSEcCtD
Foscarnet—Pruritus—Mycophenolic acid—systemic scleroderma	0.000221	0.000581	CcSEcCtD
Foscarnet—Vomiting—Azathioprine—systemic scleroderma	0.00022	0.00058	CcSEcCtD
Foscarnet—Eye disorder—Prednisone—systemic scleroderma	0.00022	0.000578	CcSEcCtD
Foscarnet—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000578	CcSEcCtD
Foscarnet—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000576	CcSEcCtD
Foscarnet—Rash—Azathioprine—systemic scleroderma	0.000218	0.000575	CcSEcCtD
Foscarnet—Dermatitis—Azathioprine—systemic scleroderma	0.000218	0.000574	CcSEcCtD
Foscarnet—Flushing—Prednisone—systemic scleroderma	0.000218	0.000574	CcSEcCtD
Foscarnet—Headache—Azathioprine—systemic scleroderma	0.000217	0.000571	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000217	0.000571	CcSEcCtD
Foscarnet—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000571	CcSEcCtD
Foscarnet—Dizziness—Leflunomide—systemic scleroderma	0.000216	0.000569	CcSEcCtD
Foscarnet—Renal failure—Methotrexate—systemic scleroderma	0.000215	0.000566	CcSEcCtD
Foscarnet—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000564	CcSEcCtD
Foscarnet—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000213	0.000562	CcSEcCtD
Foscarnet—Conjunctivitis—Methotrexate—systemic scleroderma	0.000213	0.00056	CcSEcCtD
Foscarnet—Pain—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000554	CcSEcCtD
Foscarnet—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000554	CcSEcCtD
Foscarnet—Haematuria—Methotrexate—systemic scleroderma	0.000209	0.000549	CcSEcCtD
Foscarnet—Vomiting—Leflunomide—systemic scleroderma	0.000208	0.000548	CcSEcCtD
Foscarnet—Dizziness—Mycophenolic acid—systemic scleroderma	0.000206	0.000543	CcSEcCtD
Foscarnet—Rash—Leflunomide—systemic scleroderma	0.000206	0.000543	CcSEcCtD
Foscarnet—Dermatitis—Leflunomide—systemic scleroderma	0.000206	0.000542	CcSEcCtD
Foscarnet—Nausea—Azathioprine—systemic scleroderma	0.000206	0.000542	CcSEcCtD
Foscarnet—Headache—Leflunomide—systemic scleroderma	0.000205	0.000539	CcSEcCtD
Foscarnet—Agranulocytosis—Methotrexate—systemic scleroderma	0.000204	0.000537	CcSEcCtD
Foscarnet—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000203	0.000534	CcSEcCtD
Foscarnet—Asthenia—Lisinopril—systemic scleroderma	0.000202	0.000531	CcSEcCtD
Foscarnet—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000201	0.00053	CcSEcCtD
Foscarnet—Pruritus—Lisinopril—systemic scleroderma	0.000199	0.000524	CcSEcCtD
Foscarnet—Vomiting—Mycophenolic acid—systemic scleroderma	0.000198	0.000522	CcSEcCtD
Foscarnet—Rash—Mycophenolic acid—systemic scleroderma	0.000197	0.000518	CcSEcCtD
Foscarnet—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000197	0.000518	CcSEcCtD
Foscarnet—Headache—Mycophenolic acid—systemic scleroderma	0.000195	0.000515	CcSEcCtD
Foscarnet—Pharyngitis—Methotrexate—systemic scleroderma	0.000195	0.000513	CcSEcCtD
Foscarnet—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000513	CcSEcCtD
Foscarnet—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000513	CcSEcCtD
Foscarnet—Nausea—Leflunomide—systemic scleroderma	0.000194	0.000512	CcSEcCtD
Foscarnet—Urethral disorder—Methotrexate—systemic scleroderma	0.000192	0.000507	CcSEcCtD
Foscarnet—Diarrhoea—Lisinopril—systemic scleroderma	0.000192	0.000506	CcSEcCtD
Foscarnet—Ill-defined disorder—Prednisone—systemic scleroderma	0.00019	0.0005	CcSEcCtD
Foscarnet—Anaemia—Prednisone—systemic scleroderma	0.000189	0.000498	CcSEcCtD
Foscarnet—Agitation—Prednisone—systemic scleroderma	0.000188	0.000495	CcSEcCtD
Foscarnet—Dizziness—Lisinopril—systemic scleroderma	0.000186	0.000489	CcSEcCtD
Foscarnet—Erythema multiforme—Methotrexate—systemic scleroderma	0.000186	0.000489	CcSEcCtD
Foscarnet—Nausea—Mycophenolic acid—systemic scleroderma	0.000185	0.000488	CcSEcCtD
Foscarnet—Malaise—Prednisone—systemic scleroderma	0.000184	0.000486	CcSEcCtD
Foscarnet—Eye disorder—Methotrexate—systemic scleroderma	0.000183	0.000483	CcSEcCtD
Foscarnet—Vomiting—Lisinopril—systemic scleroderma	0.000179	0.00047	CcSEcCtD
Foscarnet—Rash—Lisinopril—systemic scleroderma	0.000177	0.000467	CcSEcCtD
Foscarnet—Convulsion—Prednisone—systemic scleroderma	0.000177	0.000467	CcSEcCtD
Foscarnet—Dermatitis—Lisinopril—systemic scleroderma	0.000177	0.000466	CcSEcCtD
Foscarnet—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000465	CcSEcCtD
Foscarnet—Hypertension—Prednisone—systemic scleroderma	0.000177	0.000465	CcSEcCtD
Foscarnet—Chills—Methotrexate—systemic scleroderma	0.000176	0.000464	CcSEcCtD
Foscarnet—Headache—Lisinopril—systemic scleroderma	0.000176	0.000464	CcSEcCtD
Foscarnet—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000459	CcSEcCtD
Foscarnet—Arthralgia—Prednisone—systemic scleroderma	0.000174	0.000458	CcSEcCtD
Foscarnet—Myalgia—Prednisone—systemic scleroderma	0.000174	0.000458	CcSEcCtD
Foscarnet—Anxiety—Prednisone—systemic scleroderma	0.000174	0.000457	CcSEcCtD
Foscarnet—Discomfort—Prednisone—systemic scleroderma	0.000172	0.000453	CcSEcCtD
Foscarnet—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000444	CcSEcCtD
Foscarnet—Nausea—Lisinopril—systemic scleroderma	0.000167	0.00044	CcSEcCtD
Foscarnet—Oedema—Prednisone—systemic scleroderma	0.000167	0.000439	CcSEcCtD
Foscarnet—Infection—Prednisone—systemic scleroderma	0.000166	0.000437	CcSEcCtD
Foscarnet—Back pain—Methotrexate—systemic scleroderma	0.000165	0.000435	CcSEcCtD
Foscarnet—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000163	0.000429	CcSEcCtD
Foscarnet—Hyperhidrosis—Prednisone—systemic scleroderma	0.000161	0.000425	CcSEcCtD
Foscarnet—Anorexia—Prednisone—systemic scleroderma	0.000159	0.000419	CcSEcCtD
Foscarnet—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000159	0.000418	CcSEcCtD
Foscarnet—Anaemia—Methotrexate—systemic scleroderma	0.000158	0.000416	CcSEcCtD
Foscarnet—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000157	0.000412	CcSEcCtD
Foscarnet—Rash—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000409	CcSEcCtD
Foscarnet—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000408	CcSEcCtD
Foscarnet—Headache—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000406	CcSEcCtD
Foscarnet—Malaise—Methotrexate—systemic scleroderma	0.000154	0.000406	CcSEcCtD
Foscarnet—Leukopenia—Methotrexate—systemic scleroderma	0.000153	0.000403	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000152	0.0004	CcSEcCtD
Foscarnet—Insomnia—Prednisone—systemic scleroderma	0.000151	0.000397	CcSEcCtD
Foscarnet—Paraesthesia—Prednisone—systemic scleroderma	0.00015	0.000395	CcSEcCtD
Foscarnet—Cough—Methotrexate—systemic scleroderma	0.000149	0.000393	CcSEcCtD
Foscarnet—Convulsion—Methotrexate—systemic scleroderma	0.000148	0.00039	CcSEcCtD
Foscarnet—Dyspepsia—Prednisone—systemic scleroderma	0.000147	0.000387	CcSEcCtD
Foscarnet—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000385	CcSEcCtD
Foscarnet—Chest pain—Methotrexate—systemic scleroderma	0.000146	0.000383	CcSEcCtD
Foscarnet—Arthralgia—Methotrexate—systemic scleroderma	0.000146	0.000383	CcSEcCtD
Foscarnet—Myalgia—Methotrexate—systemic scleroderma	0.000146	0.000383	CcSEcCtD
Foscarnet—Decreased appetite—Prednisone—systemic scleroderma	0.000145	0.000382	CcSEcCtD
Foscarnet—Fatigue—Prednisone—systemic scleroderma	0.000144	0.000379	CcSEcCtD
Foscarnet—Discomfort—Methotrexate—systemic scleroderma	0.000144	0.000379	CcSEcCtD
Foscarnet—Constipation—Prednisone—systemic scleroderma	0.000143	0.000376	CcSEcCtD
Foscarnet—Confusional state—Methotrexate—systemic scleroderma	0.000141	0.00037	CcSEcCtD
Foscarnet—Infection—Methotrexate—systemic scleroderma	0.000139	0.000365	CcSEcCtD
Foscarnet—Feeling abnormal—Prednisone—systemic scleroderma	0.000138	0.000362	CcSEcCtD
Foscarnet—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000137	0.00036	CcSEcCtD
Foscarnet—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000136	0.000359	CcSEcCtD
Foscarnet—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000135	0.000355	CcSEcCtD
Foscarnet—Anorexia—Methotrexate—systemic scleroderma	0.000133	0.00035	CcSEcCtD
Foscarnet—Body temperature increased—Prednisone—systemic scleroderma	0.000132	0.000347	CcSEcCtD
Foscarnet—Abdominal pain—Prednisone—systemic scleroderma	0.000132	0.000347	CcSEcCtD
Foscarnet—Hypotension—Methotrexate—systemic scleroderma	0.00013	0.000343	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000127	0.000335	CcSEcCtD
Foscarnet—Insomnia—Methotrexate—systemic scleroderma	0.000126	0.000332	CcSEcCtD
Foscarnet—Paraesthesia—Methotrexate—systemic scleroderma	0.000125	0.00033	CcSEcCtD
Foscarnet—Dyspnoea—Methotrexate—systemic scleroderma	0.000124	0.000327	CcSEcCtD
Foscarnet—Somnolence—Methotrexate—systemic scleroderma	0.000124	0.000327	CcSEcCtD
Foscarnet—Dyspepsia—Methotrexate—systemic scleroderma	0.000123	0.000323	CcSEcCtD
Foscarnet—Decreased appetite—Methotrexate—systemic scleroderma	0.000121	0.000319	CcSEcCtD
Foscarnet—Fatigue—Methotrexate—systemic scleroderma	0.00012	0.000317	CcSEcCtD
Foscarnet—Asthenia—Prednisone—systemic scleroderma	0.00012	0.000315	CcSEcCtD
Foscarnet—Pain—Methotrexate—systemic scleroderma	0.000119	0.000314	CcSEcCtD
Foscarnet—Pruritus—Prednisone—systemic scleroderma	0.000118	0.000311	CcSEcCtD
Foscarnet—Feeling abnormal—Methotrexate—systemic scleroderma	0.000115	0.000303	CcSEcCtD
Foscarnet—Diarrhoea—Prednisone—systemic scleroderma	0.000114	0.000301	CcSEcCtD
Foscarnet—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000114	0.0003	CcSEcCtD
Foscarnet—Dizziness—Prednisone—systemic scleroderma	0.00011	0.000291	CcSEcCtD
Foscarnet—Abdominal pain—Methotrexate—systemic scleroderma	0.00011	0.00029	CcSEcCtD
Foscarnet—Body temperature increased—Methotrexate—systemic scleroderma	0.00011	0.00029	CcSEcCtD
Foscarnet—Vomiting—Prednisone—systemic scleroderma	0.000106	0.000279	CcSEcCtD
Foscarnet—Rash—Prednisone—systemic scleroderma	0.000105	0.000277	CcSEcCtD
Foscarnet—Dermatitis—Prednisone—systemic scleroderma	0.000105	0.000277	CcSEcCtD
Foscarnet—Headache—Prednisone—systemic scleroderma	0.000105	0.000275	CcSEcCtD
Foscarnet—Asthenia—Methotrexate—systemic scleroderma	0.0001	0.000264	CcSEcCtD
Foscarnet—Nausea—Prednisone—systemic scleroderma	9.91e-05	0.000261	CcSEcCtD
Foscarnet—Pruritus—Methotrexate—systemic scleroderma	9.87e-05	0.00026	CcSEcCtD
Foscarnet—Diarrhoea—Methotrexate—systemic scleroderma	9.54e-05	0.000251	CcSEcCtD
Foscarnet—Dizziness—Methotrexate—systemic scleroderma	9.22e-05	0.000243	CcSEcCtD
Foscarnet—Vomiting—Methotrexate—systemic scleroderma	8.87e-05	0.000234	CcSEcCtD
Foscarnet—Rash—Methotrexate—systemic scleroderma	8.8e-05	0.000232	CcSEcCtD
Foscarnet—Dermatitis—Methotrexate—systemic scleroderma	8.79e-05	0.000231	CcSEcCtD
Foscarnet—Headache—Methotrexate—systemic scleroderma	8.74e-05	0.00023	CcSEcCtD
Foscarnet—Nausea—Methotrexate—systemic scleroderma	8.29e-05	0.000218	CcSEcCtD
